One-Year Real-World Outcomes of Intravitreal Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration in Japan: A Multicenter Retrospective Study

20260 citationsJournal Articlegold Open Access

Authors

Rikuto Mizuma · Yokohama City University

Yuki Mizuki · Yokohama Minami Kyosai Hospital

A Kamata · International Goodwill Hospital

Junji Onishi · International Goodwill Hospital

Takuto Sakono · Yokohama City University

Misa Suzuki · Minamiaoyama Eye Clinic

Nobuhisa Mizuki ·

Abstract

In this Japanese real-world nAMD cohort, significant CST reduction was observed over 12 months, while visual acuity remained stable. Longer dosing intervals were also observed after switching.

Topics & Keywords

Retinal Diseases and Treatments Ophthalmology and Visual Impairment Studies Retinal Imaging and Analysis

Publication Details

Published in: Clinical ophthalmology

Volume Volume 20, pp. 1-9

DOI: 10.2147/opth.s596218

Field-Weighted Citation Impact: 0.00

Command Palette

One-Year Real-World Outcomes of Intravitreal Aflibercept 8 mg for Neovascular Age-Related Macular Degeneration in Japan: A Multicenter Retrospective Study

Authors

Abstract

Topics & Keywords

Publication Details